@article{6e2942ce55c54ecd821607a5706fdcc6,
title = "Exome-wide rare variant analyses of two bone mineral density phenotypes: The challenges of analyzing rare genetic variation",
abstract = "Performance of a recently developed test for association between multivariate phenotypes and sets of genetic variants (MURAT) is demonstrated using measures of bone mineral density (BMD). By combining individual-level whole genome sequenced data from the UK10K study, and imputed genome-wide genetic data on individuals from the Study of Osteoporotic Fractures (SOF) and the Osteoporotic Fractures in Men Study (MrOS), a data set of 8810 individuals was assembled; tests of association were performed between autosomal gene-sets of genetic variants and BMD measured at lumbar spine and femoral neck. Distributions of p-values obtained from analyses of a single BMD phenotype are compared to those from the multivariate tests, across several region definitions and variant weightings. There is evidence of increased power with the multivariate test, although no new loci for BMD were identified. Among 17 genes highlighted either because there were significant p-values in region-based association tests or because they were in well-known BMD genes, 4 windows in 2 genes as well as 6 single SNPs in one of these genes showed association at genome-wide significant thresholds with the multivariate phenotype test but not with the single-phenotype test, Sequence Kernel Association Test (SKAT).",
author = "Jianping Sun and Karim Oualkacha and Vincenzo Forgetta and Zheng, {Hou Feng} and Richards, {J. Brent} and Evans, {Daniel S.} and Eric Orwoll and Greenwood, {Celia M.T.}",
note = "Funding Information: This work was supported by the Canadian Institutes of Health Research operating grant MOP115110 (CG). The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research under the following grant numbers: U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, and UL1 TR000128. NIAMS provided funding for the MrOS ancillary study {\textquoteleft}Replication of candidate gene associations and bone strength phenotype in MrOS{\textquoteright} under the grant number R01 AR051124. The Study of Osteoporotic Fractures (SOF) is supported by National Institutes of Health funding. The National Institute on Aging (NIA) provides support under the following grant numbers: R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, and R01 AG027576. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) provides funding for the MrOS ancillary study {\textquoteleft}GWAS in MrOS and SOF{\textquoteright} under the grant number RC2 AR058973. This study makes use of data generated by the UK10K Consortium. Funding for UK10K was provided by the Wellcome Trust under award WT091310. The Twins UK study was also funded by the Wellcome Trust; European Community{\textquoteright}s Seventh Framework Programme (FP7/2007–2013). Publisher Copyright: {\textcopyright} 2017 The Author(s).",
year = "2018",
month = dec,
day = "1",
doi = "10.1038/s41598-017-18385-9",
language = "English (US)",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",
}